AMP-101

N/A

Report date: 2024/11/13 11:36:26

Base Information

Drug NameAMP-101
Drug Alias NameAMP101AAVD7AAVDok7
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionProtein Dok-7 gene transference
TargetsProtein Dok-7
Therapy Area/IndicationsMyasthenic Syndromes, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Tokyo
China Registration ClassN/A

Develop Information

Active CompaniesAmplo Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsMyasthenic Syndromes, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A